Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Embryonic Stem Cells | 3 | 2022 | 1246 | 1.230 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2022 | 101 | 0.770 |
Why?
|
ADP-Ribosylation Factors | 5 | 2015 | 133 | 0.700 |
Why?
|
Lysosomes | 4 | 2015 | 921 | 0.680 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2020 | 3596 | 0.550 |
Why?
|
MicroRNAs | 2 | 2020 | 3758 | 0.400 |
Why?
|
Proteolipids | 1 | 2011 | 113 | 0.380 |
Why?
|
Gene Regulatory Networks | 1 | 2020 | 1743 | 0.370 |
Why?
|
Natural Killer T-Cells | 2 | 2011 | 322 | 0.360 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2016 | 799 | 0.340 |
Why?
|
Pluripotent Stem Cells | 1 | 2016 | 794 | 0.330 |
Why?
|
Protein Biosynthesis | 1 | 2016 | 2091 | 0.320 |
Why?
|
Antigen Presentation | 6 | 2015 | 1251 | 0.310 |
Why?
|
Antigens | 2 | 2015 | 1441 | 0.270 |
Why?
|
Cell Differentiation | 2 | 2022 | 11509 | 0.260 |
Why?
|
RNA Interference | 1 | 2015 | 2816 | 0.260 |
Why?
|
Single-Cell Analysis | 1 | 2016 | 2451 | 0.240 |
Why?
|
Antigens, CD1 | 5 | 2012 | 439 | 0.230 |
Why?
|
Gene Expression Profiling | 2 | 2020 | 9416 | 0.230 |
Why?
|
Transcription Factors | 2 | 2022 | 12099 | 0.220 |
Why?
|
Gene Expression Regulation | 3 | 2022 | 11856 | 0.220 |
Why?
|
Protein Transport | 6 | 2015 | 1958 | 0.210 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2022 | 89 | 0.190 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2021 | 127 | 0.180 |
Why?
|
Proteins | 1 | 2015 | 5993 | 0.170 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2013 | 1351 | 0.160 |
Why?
|
SOXB1 Transcription Factors | 1 | 2020 | 286 | 0.150 |
Why?
|
Salivary Gland Neoplasms | 1 | 2022 | 304 | 0.150 |
Why?
|
Endocytosis | 3 | 2012 | 950 | 0.150 |
Why?
|
Oncogenes | 1 | 2022 | 1220 | 0.140 |
Why?
|
Enhancer Elements, Genetic | 1 | 2022 | 1360 | 0.130 |
Why?
|
rab GTP-Binding Proteins | 3 | 2012 | 245 | 0.120 |
Why?
|
HeLa Cells | 5 | 2013 | 3073 | 0.120 |
Why?
|
Paclitaxel | 1 | 2021 | 1730 | 0.110 |
Why?
|
Antigens, CD1d | 2 | 2011 | 228 | 0.110 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2015 | 1435 | 0.100 |
Why?
|
RNA-Binding Proteins | 1 | 2020 | 1855 | 0.090 |
Why?
|
Endosomes | 5 | 2015 | 518 | 0.090 |
Why?
|
Cytoplasmic Granules | 1 | 2013 | 573 | 0.090 |
Why?
|
Education, Graduate | 1 | 2011 | 75 | 0.090 |
Why?
|
Chromatin | 1 | 2022 | 2946 | 0.090 |
Why?
|
GTP Phosphohydrolases | 1 | 2013 | 517 | 0.090 |
Why?
|
Animals | 11 | 2022 | 168079 | 0.090 |
Why?
|
Allergy and Immunology | 1 | 2011 | 177 | 0.080 |
Why?
|
Galactosylceramides | 1 | 2009 | 92 | 0.080 |
Why?
|
Mice | 7 | 2022 | 81326 | 0.080 |
Why?
|
Vesicular Transport Proteins | 1 | 2011 | 374 | 0.080 |
Why?
|
Dendritic Cells | 3 | 2015 | 2726 | 0.070 |
Why?
|
Killer Cells, Natural | 2 | 2013 | 2194 | 0.070 |
Why?
|
Research Personnel | 1 | 2011 | 588 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2021 | 5300 | 0.070 |
Why?
|
Parasites | 1 | 2009 | 160 | 0.070 |
Why?
|
RNA, Small Interfering | 2 | 2015 | 3412 | 0.070 |
Why?
|
Fungi | 1 | 2009 | 337 | 0.060 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2010 | 1348 | 0.060 |
Why?
|
Lymphocyte Activation | 3 | 2011 | 5478 | 0.060 |
Why?
|
Mice, Knockout | 1 | 2020 | 14392 | 0.060 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13632 | 0.050 |
Why?
|
Protein Binding | 2 | 2012 | 9297 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2015 | 4372 | 0.050 |
Why?
|
Gene Expression | 1 | 2015 | 7571 | 0.050 |
Why?
|
Antigen-Presenting Cells | 1 | 2005 | 965 | 0.050 |
Why?
|
Stathmin | 1 | 2021 | 70 | 0.050 |
Why?
|
Apolipoproteins E | 1 | 2005 | 1443 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2015 | 18926 | 0.040 |
Why?
|
Signal Transduction | 2 | 2020 | 23416 | 0.040 |
Why?
|
Bacteria | 1 | 2009 | 2190 | 0.040 |
Why?
|
Workflow | 1 | 2022 | 850 | 0.040 |
Why?
|
Drug Synergism | 1 | 2021 | 1756 | 0.040 |
Why?
|
Gene Knockdown Techniques | 1 | 2021 | 1602 | 0.030 |
Why?
|
Gene Silencing | 2 | 2013 | 1495 | 0.030 |
Why?
|
Humans | 14 | 2022 | 761208 | 0.030 |
Why?
|
T-Lymphocytes | 3 | 2009 | 10203 | 0.030 |
Why?
|
Cytokines | 1 | 2011 | 7386 | 0.030 |
Why?
|
Translocation, Genetic | 1 | 2022 | 1391 | 0.030 |
Why?
|
Lipids | 1 | 2005 | 3331 | 0.030 |
Why?
|
Microtubule-Organizing Center | 1 | 2013 | 25 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2022 | 1605 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22140 | 0.030 |
Why?
|
Immunological Synapses | 1 | 2013 | 58 | 0.030 |
Why?
|
Ovalbumin | 1 | 2015 | 671 | 0.030 |
Why?
|
Chickens | 1 | 2015 | 857 | 0.030 |
Why?
|
Trans-Activators | 1 | 2022 | 2846 | 0.030 |
Why?
|
Exocytosis | 1 | 2013 | 320 | 0.020 |
Why?
|
Cell Membrane | 2 | 2012 | 3661 | 0.020 |
Why?
|
Transferrin | 1 | 2012 | 283 | 0.020 |
Why?
|
Transfection | 2 | 2010 | 5748 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2012 | 489 | 0.020 |
Why?
|
Medical Oncology | 1 | 2022 | 2320 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2021 | 16952 | 0.020 |
Why?
|
beta 2-Microglobulin | 1 | 2010 | 329 | 0.020 |
Why?
|
Glycosides | 1 | 2009 | 100 | 0.020 |
Why?
|
Protein Modification, Translational | 1 | 2008 | 21 | 0.020 |
Why?
|
Spleen | 1 | 2015 | 2290 | 0.020 |
Why?
|
Cell Line | 2 | 2015 | 15545 | 0.020 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2009 | 274 | 0.020 |
Why?
|
Protein Stability | 1 | 2010 | 579 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3788 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2022 | 5782 | 0.020 |
Why?
|
Receptors, Leptin | 1 | 2009 | 350 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2015 | 2410 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2012 | 2062 | 0.020 |
Why?
|
Membrane Microdomains | 1 | 2008 | 205 | 0.020 |
Why?
|
Models, Chemical | 1 | 2009 | 609 | 0.020 |
Why?
|
Clathrin | 1 | 2008 | 256 | 0.020 |
Why?
|
Universities | 1 | 2011 | 995 | 0.020 |
Why?
|
Peer Group | 1 | 2011 | 691 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2012 | 3778 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2012 | 2706 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2021 | 10422 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8530 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2010 | 2477 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2010 | 1695 | 0.020 |
Why?
|
Protein Subunits | 1 | 2008 | 940 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2022 | 9566 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5333 | 0.010 |
Why?
|
Drug Design | 1 | 2009 | 1045 | 0.010 |
Why?
|
Th2 Cells | 1 | 2009 | 1071 | 0.010 |
Why?
|
Cytoplasm | 1 | 2008 | 1498 | 0.010 |
Why?
|
Multiprotein Complexes | 1 | 2010 | 1112 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2013 | 2897 | 0.010 |
Why?
|
Receptors, LDL | 1 | 2005 | 489 | 0.010 |
Why?
|
Mutation | 2 | 2021 | 30002 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2008 | 1838 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2010 | 6504 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2009 | 2549 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 2011 | 2374 | 0.010 |
Why?
|
Boston | 1 | 2011 | 9327 | 0.010 |
Why?
|
Curriculum | 1 | 2011 | 3741 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 54435 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2005 | 1893 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13385 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2015 | 22127 | 0.010 |
Why?
|
Concepts
(133)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(50)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_